SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-23-028055
Filing Date
2023-08-14
Accepted
2023-08-14 08:10:45
Documents
34
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 636688
2 ex31-1.htm EX-31.1 17756
3 ex31-2.htm EX-31.2 17557
4 ex32-1.htm EX-32.1 7701
  Complete submission text file 0001493152-23-028055.txt   2400130

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE vblt-20230630.xsd EX-101.SCH 18615
6 XBRL CALCULATION FILE vblt-20230630_cal.xml EX-101.CAL 31242
7 XBRL DEFINITION FILE vblt-20230630_def.xml EX-101.DEF 65327
8 XBRL LABEL FILE vblt-20230630_lab.xml EX-101.LAB 186456
9 XBRL PRESENTATION FILE vblt-20230630_pre.xml EX-101.PRE 131806
28 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 166045
Mailing Address HASATAT 8 ST. MODI'IN, L3 7178106
Business Address HASATAT 8 ST. MODI'IN, L3 7178106 972-3-6346450
Vascular Biogenics Ltd. (Filer) CIK: 0001603207 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36581 | Film No.: 231166442
SIC: 2834 Pharmaceutical Preparations